Loading
Peijia Medical Ltd. - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Oesterle Stephen Newman, was filed 06 Jul 2026.
Peijia Medical Ltd. - B: what insiders have been doing
Peijia Medical Ltd. - B belongs to the Health Care sector. Filings by its managers are published through HKEX. 5 insiders have disclosed 27 filings since 23 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 27 purchases totalling €32.1M, made by 5 insiders. No amount is published for 6 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €29.7M by Zhang Ping Ye, published on 22 May 2026, equal to 8.5% of the market capitalisation. The buyers include 5 senior executives.
Across the 1,315 companies tracked on its exchange, the median is 4 filings; at 27 filings, this issuer sits above that mark. Our records for Peijia Medical Ltd. - B go back to 2020, with 79 purchases and 7 sales on the open market in total.
In all, 25 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The latest purchase dates back some time: it was published 110 days ago, on 6 July 2026. The median gap between a trade and its publication by HKEX is 5 days. This delay matters because a trade only becomes useful information once it is public.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
145
Thresholds
n/a
Buy Volume
€33M
79 ops. · all time
Sell Volume
€2M
7 ops. · all time
Who traded when
BuySaleYe Hong18 buys
Oesterle Stephen Newman7 buys
Parks Robert Ralph7 buys
Zhang Ping Ye2 buys
Zhang Yi1 buy
Since the insiders bought
- -5.6%Entry HK$4.08 · Close 22 Oct 2026 HK$3.85
- -5.6%Entry HK$4.08 · Close 22 Oct 2026 HK$3.85
- +15.7%Entry HK$4.39 · Close at T+90 HK$5.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,233 of 26,280 companies
26.9
score / 100
Value17
Quality37
FCF yld-12%
Earn yld-7.3%
EV/EBITDA·
ROE-7.6%
Gross mgn68%
Net mgn-29%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$4.17
Analyst consensus
4 analysts1.25/5
HK$8.66Target HK$9.86(+136%)HK$10.77
Income statement
RevenueHK$712.9M
Gross profitHK$486.1M68% margin
EBITDA-HK$123M-17% margin
Net income-HK$203.3M-18.0% margin
Valuation
PER (forward)29.8x
P/Book1.3x
Beta0.61
Balance sheet & cash
Market capHK$2.8B
Total debtHK$434M
Free Cash Flow-HK$325.3M
Debt / Equity35%
Profitability & ownership
ROE-7.6%
ROA-2.2%
% insiders24.8%
% institutions16.1%
Last declaration on 6 July 2026
Declarations145 total
49,109 sharesShareXHKGHKEX:DA20260703E00475
Canonical exit: 28 Sept 2026 (T+90)
49,109 sharesShareXHKGHKEX:DA20260703E00532
Canonical exit: 28 Sept 2026 (T+90)
45,000 shares@ HK$4.4540.0063% mcap0.1% of flowShareXHKGHKEX:DA20260608E00015
Canonical exit: 1 Sept 2026 (T+90)
45,000 shares@ HK$4.4540.0063% mcap0.1% of flowShareXHKGHKEX:DA20260608E00007
Canonical exit: 1 Sept 2026 (T+90)
45,000 shares@ HK$4.4540.0063% mcap0.1% of flowShareXHKGHKEX:DA20260608E00006
Canonical exit: 1 Sept 2026 (T+90)
500,000 shares@ HK$4.87810.087% mcap0.9% of flowShareXHKGHKEX:DA20260602E00018
Canonical exit: 26 Aug 2026 (T+90)
500,000 shares@ HK$4.87810.087% mcap0.9% of flowShareXHKGHKEX:DA20260602E00014
Canonical exit: 26 Aug 2026 (T+90)
500,000 shares@ HK$4.87810.087% mcap0.9% of flowShareXHKGHKEX:DA20260602E00015
Canonical exit: 26 Aug 2026 (T+90)
600,000 shares@ HK$5.41638.48% mcap95.3% of flowShareXHKGHKEX:DA20260521E00372
Canonical exit: 16 Aug 2026 (T+90)
600,000 shares@ HK$5.41638.48% mcap95.3% of flowShareXHKGHKEX:DA20260521E00366
Canonical exit: 16 Aug 2026 (T+90)
600,000 shares@ HK$5.41638.48% mcap95.3% of flowShareXHKGHKEX:DA20260521E00374
Canonical exit: 16 Aug 2026 (T+90)
100,000 shares@ HK$6.18290.021% mcap0.2% of flowShareXHKGHKEX:DA20260506E00033
Canonical exit: 29 Jul 2026 (T+90)
100,000 shares@ HK$6.18290.021% mcap0.2% of flowShareXHKGHKEX:DA20260506E00034
Canonical exit: 29 Jul 2026 (T+90)
100,000 shares@ HK$6.18290.022% mcap0.2% of flowShareXHKGHKEX:DA20260506E00036
Canonical exit: 29 Jul 2026 (T+90)
307,000 shares@ HK$6.66650.068% mcap0.7% of flowShareXHKGHKEX:DA20260429E00129
Canonical exit: 23 Jul 2026 (T+90)
307,000 shares@ HK$6.66650.068% mcap0.7% of flowShareXHKGHKEX:DA20260429E00141
Canonical exit: 23 Jul 2026 (T+90)
307,000 shares@ HK$6.66650.068% mcap0.7% of flowShareXHKGHKEX:DA20260429E00146
Canonical exit: 23 Jul 2026 (T+90)
96,000 shares@ HK$6.22380.019% mcap0.2% of flowShareXHKGHKEX:DA20260414E00094
Canonical exit: 8 Jul 2026 (T+90)
96,000 shares@ HK$6.22380.019% mcap0.2% of flowShareXHKGHKEX:DA20260414E00091
Canonical exit: 8 Jul 2026 (T+90)
96,000 shares@ HK$6.22380.019% mcap0.2% of flowShareXHKGHKEX:DA20260414E00088
Canonical exit: 8 Jul 2026 (T+90)
300,000 shares@ HK$5.69590.054% mcap0.6% of flowShareXHKGHKEX:DA20260403E00117
Canonical exit: 29 Jun 2026 (T+90)
300,000 shares@ HK$5.69590.054% mcap0.6% of flowShareXHKGHKEX:DA20260403E00116
Canonical exit: 29 Jun 2026 (T+90)
300,000 shares@ HK$5.69590.054% mcap0.6% of flowShareXHKGHKEX:DA20260403E00118
Canonical exit: 29 Jun 2026 (T+90)
33,365 sharesShareXHKGHKEX:DA20260403E00135
Canonical exit: 29 Jun 2026 (T+90)
33,365 sharesShareXHKGHKEX:DA20260403E00148
Canonical exit: 29 Jun 2026 (T+90)
25 of 145 declarations
About Peijia Medical Ltd. - B
Peijia Medical Ltd. is a company focused on the development and manufacturing of medical devices, particularly in the field of cardiovascular interventions. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
